IP Verse

Subcutaneous Anti-Her2 Antibody Formulation

Patent No. EP2687202 (titled "Subcutaneous Anti-Her2 Antibody Formulation") was filed by F Hoffmann LA Roche on Jul 28, 2010. The application was issued on May 10, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ACCORD HEALTHCAREFeb 12, 2024BRAND MURRAY FULLER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2687202

F HOFFMANN LA ROCHE
Application Number
EP13166031A
Filing Date
Jul 28, 2010
Status
Granted And Under Opposition
Apr 7, 2023
Publication Date
May 10, 2023
External Links
Slate, Register , Google Patents